Zfxtm1.1Reiz/Y Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+
involves: 129/Sv * 129S6/SvEvTac
|
abnormal common lymphocyte progenitor cell morphology |
J:149654
|
abnormal hematopoietic system physiology |
J:149654
|
decreased hematopoietic stem cell number |
J:149654
|
Zfxtm1.1Reiz/Y Meox2tm1(cre)Sor/Meox2+
involves: 129S4/SvJaeSor * 129S6/SvEvTac
|
neonatal lethality, complete penetrance |
J:149654
|
Zfxtm1.1Reiz/Y Tg(Mx1-cre)1Cgn/0
involves: 129S6/SvEvTac * C57BL/6 * CBA
|
abnormal common lymphocyte progenitor cell morphology |
J:149654
|
abnormal hematopoietic system physiology |
J:149654
|
decreased hematopoietic stem cell number |
J:149654
|
decreased lymphocyte cell number |
J:149654
|
impaired hematopoiesis |
J:149654
|
Zfxtm1.1Reiz/Y Tg(Nes-cre)1Kln/0
involves: 129S6/SvEvTac * C57BL/6 * SJL
|
normal
mortality/aging |
J:149654
|
normal
nervous system phenotype |
J:149654
|
Zfxtm1.1Reiz/Y Tg(Tek-cre)12Flv/0
involves: 129S6/SvEvTac * C3H * C57BL/6
|
abnormal common lymphocyte progenitor cell morphology |
J:149654
|
abnormal hematopoietic system physiology |
J:149654
|
decreased hematopoietic stem cell number |
J:149654
|
decreased mature B cell number |
J:149654
|
decreased T cell number |
J:149654
|
Zfxtm1.1Reiz/Zfxtm1.1Reiz Meox2tm1(cre)Sor/Meox2+
involves: 129S4/SvJaeSor * 129S6/SvEvTac
|
neonatal lethality, complete penetrance |
J:149654
|
Zfxtm1.1Reiz/Zfxtm1.1Reiz Tg(Nes-cre)1Kln/0
involves: 129S6/SvEvTac * C57BL/6 * SJL
|
normal
mortality/aging |
J:149654
|
normal
nervous system phenotype |
J:149654
|
Zfxtm1.2Reiz/Y
involves: 129S6/SvEvTac * C57BL/6 * DBA/2
|
abnormal extraembryonic tissue morphology |
J:149654
|
decreased hematopoietic stem cell number |
J:149654
|
embryonic lethality during organogenesis, complete penetrance |
J:149654
|
Zfxtm1.2Reiz/Zfxtm1.2Reiz
involves: 129S6/SvEvTac * C57BL/6 * DBA/2
|
abnormal extraembryonic tissue morphology |
J:149654
|
decreased hematopoietic stem cell number |
J:149654
|
embryonic lethality during organogenesis, complete penetrance |
J:149654
|
Zfxtm1Dcp/Y
involves: 129S4/SvJae * BALB/c
|
decreased body weight |
J:41131
|
decreased embryo size |
J:41131
|
decreased primordial germ cell number |
J:41131
|
neonatal lethality, incomplete penetrance |
J:41131
|
oligozoospermia |
J:41131
|
Zfxtm1Dcp/Zfx+
involves: 129S4/SvJae * BALB/c
|
decreased germ cell number |
J:41131
|
decreased oocyte number |
J:41131
|
neonatal lethality, incomplete penetrance |
J:41131
|
Zfxtm1Dcp/Y
involves: 129S4/SvJae * C57BL/6J
|
neonatal lethality, incomplete penetrance |
J:41131
|
postnatal lethality, complete penetrance |
J:41131
|
Zfxtm1Dcp/Zfx+
involves: 129S4/SvJae * C57BL/6J
|
neonatal lethality, incomplete penetrance |
J:41131
|
postnatal lethality, incomplete penetrance |
J:41131
|
Zfxtm1Dcp/Zfxtm1Dcp
involves: 129S4/SvJae * BALB/c
|
decreased body weight |
J:41131
|
decreased embryo size |
J:41131
|
decreased mature ovarian follicle number |
J:41131
|
decreased oocyte number |
J:41131
|
decreased primordial germ cell number |
J:41131
|
neonatal lethality, incomplete penetrance |
J:41131
|
reduced female fertility |
J:41131
|
Zfxtm1Dcp/Zfxtm1Dcp
involves: 129S4/SvJae * C57BL/6J
|
abnormal embryonic growth/weight/body size |
J:41131
|
abnormal fertility/fecundity |
J:41131
|
abnormal postnatal growth/weight/body size |
J:41131
|
neonatal lethality, incomplete penetrance |
J:41131
|